152 related articles for article (PubMed ID: 11452363)
1. The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.
Geck P; Sonnenschein C; Soto AM
Am J Hum Genet; 2001 Aug; 69(2):461-3. PubMed ID: 11452363
[No Abstract] [Full Text] [Related]
2. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
Grimmond SM; Palmer JM; Walters MK; Scott C; Nancarrow DJ; Teh BT; Elmes C; Pyke C; Khoo SK; Bennett I; Wetzig N; Hayward NK
Hum Genet; 1996 Jul; 98(1):80-5. PubMed ID: 8682513
[TBL] [Abstract][Full Text] [Related]
3. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D
Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638
[TBL] [Abstract][Full Text] [Related]
4. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
Rebbeck TR; Couch FJ; Kant J; Calzone K; DeShano M; Peng Y; Chen K; Garber JE; Weber BL
Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
[TBL] [Abstract][Full Text] [Related]
5. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
[TBL] [Abstract][Full Text] [Related]
6. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.
Gudmundsson J; Johannesdottir G; Arason A; Bergthorsson JT; Ingvarsson S; Egilsson V; Barkardottir RB
Am J Hum Genet; 1996 Apr; 58(4):749-56. PubMed ID: 8644738
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
[TBL] [Abstract][Full Text] [Related]
8. A large multisite cancer family is linked to BRCA2.
Tonin P; Ghadirian P; Phelan C; Lenoir GM; Lynch HT; Letendre F; Belanger D; Monté M; Narod SA
J Med Genet; 1995 Dec; 32(12):982-4. PubMed ID: 8825930
[TBL] [Abstract][Full Text] [Related]
9. [A genetic test for breast cancer: curse or blessing?].
Sauer H
Fortschr Med; 1995 Feb; 113(4):9-10. PubMed ID: 7713472
[No Abstract] [Full Text] [Related]
10. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
[TBL] [Abstract][Full Text] [Related]
11. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma.
Nawroz-Danish HM; Koch WM; Westra WH; Yoo G; Sidransky D
Otolaryngol Head Neck Surg; 1998 Jul; 119(1):21-5. PubMed ID: 9674510
[TBL] [Abstract][Full Text] [Related]
12. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukaemia.
García-Marco JA; Navarro B; Caldas C
Br J Haematol; 1997 Dec; 99(3):708-9. PubMed ID: 9401091
[No Abstract] [Full Text] [Related]
14. Mapping of the oncogene c-myc (MYC) and the breast cancer susceptibility gene (BRCA2) in the pig by FISH.
Musilová P; Kubícková S; Vozdová M; Rubes J
Anim Genet; 2000 Apr; 31(2):154. PubMed ID: 10782232
[No Abstract] [Full Text] [Related]
15. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
[TBL] [Abstract][Full Text] [Related]
16. Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
Chung CY; Kantarjian H; Haidar M; Starostik P; Manshouri T; Gidel C; Freireich E; Keating M; Albitar M
Cancer; 2000 Mar; 88(6):1359-64. PubMed ID: 10717617
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC; Biesecker BB
Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
[TBL] [Abstract][Full Text] [Related]
18. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
19. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas.
Kelsell DP; Spurr NK; Barnes DM; Gusterson B; Bishop DT
Lancet; 1996 Jun; 347(9014):1554-5. PubMed ID: 8684125
[No Abstract] [Full Text] [Related]
20. Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.
Tong D; Kucera E; Schuster E; Schmutzler RK; Swoboda H; Reinthaller A; Leodolter S; Zeillinger R
Int J Cancer; 2000 Oct; 88(2):319-22. PubMed ID: 11004687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
